Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV
Running, not enrolling · Phase 2
Conditions studied: HIV-1 Infection
In brief
The primary objective of this study is to evaluate the efficacy of oral weekly islatravir (ISL) in combination with lenacapavir (LEN) in virologically suppressed people with HIV (PWH) at Week 24.
Key facts
- Study ID
- NCT05052996
- Run by
- Gilead Sciences
- People needed
- 142
- Starts
- 2021-10-05
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2026-02-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pacific Oaks Medical Group — Beverly Hills, California, United States
- Ruane Clinical Research Group, Inc — Los Angeles, California, United States
- Mills Clinical Research — Los Angeles, California, United States
- Hoag Medical Group - Newport Beach — Newport Beach, California, United States
- BIOS Clinical Research — Palm Springs, California, United States
- Optimus Medical Group — San Francisco, California, United States
- Public Health Institute at Denver Health — Denver, Colorado, United States
- Vivent Health — Denver, Colorado, United States
- Washington Health Institute — Washington D.C., District of Columbia, United States
- The George Washington University Medical Faculty Associates Inc. — Washington D.C., District of Columbia, United States
- CAN Community Health Care, Inc. — Fort Lauderdale, Florida, United States
- Midway Immunology and Research Center — Ft. Pierce, Florida, United States
- JEM Research Institute — Lake Worth, Florida, United States
- Schiff Center for Liver Diseases/University of Miami — Miami, Florida, United States
- Floridian Clinical Research — Miami Lakes, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- Emory University Hospital Midtown Infectious Disease Clinic — Atlanta, Georgia, United States
- Atlanta ID Group, PC — Atlanta, Georgia, United States
- Metro Infectious Disease Consultants — Decatur, Georgia, United States
- Chatham County Health Department — Savannah, Georgia, United States
- John A. Burns School of Medicine, University of Hawaii Clinics at Kaka'ako — Honolulu, Hawaii, United States
- Howard Brown Health Center — Chicago, Illinois, United States
- Northstar Healthcare — Chicago, Illinois, United States
- Indiana CTSI Clinical Research Center — Indianapolis, Indiana, United States
- Boston Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.